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Abstract
Background: Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory-tract infections in infants and young
children worldwide. Despite this, only six complete genome sequences of original strains have been previously published,
the most recent of which dates back 35 and 26 years for RSV group A and group B respectively.
Methodology/Principal Findings: We present a semi-automated sequencing method allowing for the sequencing of four
RSV whole genomes simultaneously. We were able to sequence the complete coding sequences of 13 RSV A and 4 RSV B
strains from Milwaukee collected from 1998–2010. Another 12 RSV A and 5 RSV B strains sequenced in this study cover the
majority of the genome. All RSV A and RSV B sequences were analyzed by neighbor-joining, maximum parsimony and
Bayesian phylogeny methods. Genetic diversity was high among RSV A viruses in Milwaukee including the circulation of
multiple genotypes (GA1, GA2, GA5, GA7) with GA2 persisting throughout the 13 years of the study. However, RSV B
genomes showed little variation with all belonging to the BA genotype. For RSV A, the same evolutionary patterns and
clades were seen consistently across the whole genome including all intergenic, coding, and non-coding regions sequences.
Conclusions/Significance: The sequencing strategy presented in this work allows for RSV A and B genomes to be
sequenced simultaneously in two working days and with a low cost. We have significantly increased the amount of genomic
data that is available for both RSV A and B, providing the basic molecular characteristics of RSV strains circulating in
Milwaukee over the last 13 years. This information can be used for comparative analysis with strains circulating in other
communities around the world which should also help with the development of new strategies for control of RSV,
specifically vaccine development and improvement of RSV diagnostics.
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Introduction
Human Respiratory Syncytial Virus (RSV) is the leading cause
of all lower respiratory-tract infections in infants and young
children worldwide [1]. Population dynamics and poor socioeco-
nomic conditions have contributed to the rise in the burden of
RSV especially in developing countries where the population
under 5 years of age has steeply increased within the last 30 years
[2]. Hence, the establishment of new strategies for control of RSV
has become an important task for public health authorities
especially in the areas of prevention, diagnosis, and the
development of an effective vaccine [3].
RSV is a member of the family Paraxymoviridae, subfamily
Pneumovirinae that is differentiated into two groups (A and B) based
on antigenic and genetic variability [4–6]. Studies of genetic
variability among RSV strains belonging to each of these groups
revealed the existence of distinct genetic patterns called genotypes
[7]. To date, eight genotypes for RSV group A (named GA1 to
GA7 and SAA1) [7–9] and eight for RSV group B (named BA,
GB1 to GB4, SAB1 to SAB3) [7,9,10] have been described based
on changes in the G gene. RSV B genotype BA was initially
subdivided into six subgroups (BA1 to BA6) [11–13]. This number
now increased to ten subgroups to include four recently emerged
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25468genotypes (BA7 to BA10) [14]. Two new variants of the RSV A
genotype GA2 (NA1 and NA2) have only been described in Japan
[15].
Most epidemiological and evolutionary studies reported world-
wide for RSV have been based on the analysis of changes observed
in just part of the G protein, which is one of the most variable
among a total of 11 proteins encoded in the 15.2 Kb RSV genome
[7,9,16,17]. Those studies have provided a significant number of
small fractions from different RSV genomes, however, only six
complete genome sequences of original RSV strains have been
published (GenBank: AY911262, M74568, U39662, FJ614813,
AF013254 and AY353550). The most recent of which dates back
35 and 26 years for RSV A [18] and RSV B [19], respectively.
The lack of efficient sequencing methods available for RSV has in
part contributed to the limited knowledge of RSV evolution and
virology at a genomic level.
This work was performed in an effort to develop a cost- and
time-effective strategy for sequencing the whole genome of the
RSV groups A and B facilitating a comprehensive study of the
evolutionary characteristics of the RSV A and B strains circulating
in Milwaukee over the last 13 years. Our work significantly
increases the amount of complete genomic data that is available
for both RSV groups A and B. Here we provide basic molecular
characteristics of RSV that can be used for comparative analysis
with strains circulating in other regions of the world, which should
improve RSV control strategies, including vaccine development
and improvement of RSV diagnostics.
Materials and Methods
Ethics Statement
All clinical samples were collected under protocols allowing
sequencing approved by the Medical College of Wisconsin and
Children’s Hospital of Wisconsin institutional review boards. Some
samples were approved to be collected retrospectively, de-identified,
and did not require consent. The remaining samples were collected
with written informed consent (from parent/guardian).
Source of Clinical Samples and Isolation of the Virus
All specimens (Table 1) were collected from patients in the
Milwaukee metro area by nasopharyngeal and nasal swabs and
were immediately added to 3.0 ml of M4 viral transport medium
(Remel, Lenexa, KS). Clinical samples were either collected with
written informed consent (from parent/guardian) or received de-
identified from the Children’s Hospital of Wisconsin or Dynacare
Laboratories with an IRB approved waiver of consent. Samples
from 2006–2010 were determined to be positive by real-time RT-
PCR [20], while samples from 1998 were determined to be
positive by the Hexaplex assay [21].
In order to preserve the strains in this study we attempted to
isolate RSV from many of the clinical samples by applying
standard virus culture techniques using the epithelial cell line
HEP-2 (ATCC, Manassas, VA). HEP-2 cells were inoculated with
sample and incubated at 37uC with 5% CO2 in a humidified
incubator for up to 10–14 days. Virus was harvested upon
visualization of the characteristic RSV cytopathic effect, syncytium
formation. Not all RSV strains could be isolated.
Primer Design
PCR amplification primer pairs (IDT-DNA technologies,
Coralville, IA) were designed for highly conserved regions to
encompass both RSV A and RSV B strains based on sequence
data from GenBank. Additional primers were designed from our
sequence data as necessary. Degenerate bases were used in place
of genetically variable bases across RSV A and RSV B strains
when necessary. The RSV genome was divided into 12–13
overlapping segments for sequencing, with some segments utilizing
several alternate primer pairs (Table S1 and Figure S1). Variability
and length of a given segment dictated the number of internal
overlapping sequencing primers designed for said segment to allow
for complete coverage of the genome.
Table 1. Milwaukee RSV strains sequenced.
RSV A
Strain Isolation Date Source
% Genome
Sequenced
(1)
A/WI/629-3248/98 1/6/1998 Sample 99.4
A/WI/629-4071/98 1/9/1998 Isolate 99.6
A/WI/629-4111/98 1/27/1998 Sample 96.8
A/WI/629-3868/98 2/18/1998 Sample 95.0
A/WI/629-4110/98 3/5/1998 Sample 91.1
A/WI/629-3734/98 3/9/1998 Sample 98.4
A/WI/629-4239/98 3/21/1998 Sample 99.6
A/WI/629-4255/98 3/29/1998 Sample 95.5
A/WI/629-4266/98 4/14/1998 Sample 85.9
A/WI/629-4285/98 5/2/1998 Sample 92.7
A/WI/629-4302/98 5/17/1998 Sample 97.1
A/WI/629-4480/98 11/14/1998 Sample 59.9
A/WI/629-3/06-07 2006-7 Isolate 99.6
A/WI/629-9/06-07 2006-7 Sample 96.2
A/WI/629-17/06-07 2006-7 Isolate 99.6
A/WI/629-2/07 2007 Isolate 99.6
A/WI/629-9-2/07 2007 Isolate 99.6
A/WI/629-21/07 12/22/2007 Isolate 99.4
A/WI/629-22/07 12/28/2007 Isolate 99.6
A/WI/629-23/08 1/17/2008 Isolate 99.4
A/WI/629-DC9/08-09 2008-9 Isolate 99.6
A/WI/629-Q0154/10 1/13/2010 Sample 99.6
A/WI/629-Q0198/10 1/25/2010 Sample 98.2
A/WI/629-Q0282/10 2/16/2010 Sample 99.3
A/WI/629-Q0284/10 2/16/2010 Isolate 99.3
RSV B
B/WI/629-5B/06-07 2006-7 Isolate 99.6
B/WI/629-12/06-07 2006-7 Sample 99.6
B/WI/629-15/06-07 2006-7 Sample 99.6
B/WI/629-DC1/08-09 2008-9 Sample 99.5
B/WI/629-DC2/08-09 2008-9 Sample 92.6
B/WI/629-DC8/08-09 2008-9 Sample 91.2
B/WI/629-DC10/08-09 2008-9 Sample 74.4
B/WI/629-Q0190/10 1/21/2010 Sample 99.6
B/WI/629-Q0306/10 3/3/2010 Sample 88.2
(1)The percent of the genome sequenced for each of the isolate/sample was
calculated as the length (nt) of each isolate/sample sequenced divided by the
total length (nt) of the prototype strain published for RSV. Previous to this
calculation the sequences of the isolates/samples for RSV group A and group
B were aligned to the prototype strains for RSV group A (M74568) and group
B (AF013254) respectively.
doi:10.1371/journal.pone.0025468.t001
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RNA from clinical isolates and some clinical samples was
extracted using the semi-automated NucliSENS easyMAG System
(Biomerieux, Durham, NC) by combining 400 mL of sample with
1 mL of easyMAG Lysis Buffer for no less than 10 minutes.
Samples were extracted following the manufacturer’s generic
automated 1.0 protocol for off-board lysis and nucleic acid was
eluted into 50 mL of elution buffer. Extracted RNA from clinical
samples and clinical isolates were handled identically post
extraction and were used either directly or frozen at 280uC until
needed.
Additional clinical samples were manually extracted with the
RNeasy Mini Kit (QIAGEN, Valencia, CA). Samples were lysed
by combining 400 ml of RLT buffer with 400 mL of clinical sample
and incubating at ambient temperature for five minutes. Following
the addition of 200 mL of 70% ethanol the lysate was processed
according to the manufacturer’s protocol. RNA was eluted in
50 ml RNase free water which was added to the spin column two
minutes prior to centrifugation to increase elution efficiency.
Two-step RT-PCR
Following extraction, 20 mL reverse transcription reactions were
prepared containing 3 mL of RNA, 2.5 mM Random Hexamers,
4 mM dNTP Mix, 1x PCR Buffer II, 5 mM MgCl2, 2.5 U
MuLV, and 1 U Rnase Inhibitor (Applied Biosystems, Carlsbad,
CA). The reaction was performed on a GeneAmp 9700
thermocycler (Applied Biosystems) under the following conditions:
5 min at 22uC, 30 min at 42uC, and 5 min at 95uC. For every
clinical sample or isolate, seven RT reactions were performed in
order to prepare enough cDNA for 12–13 PCR reactions.
Each PCR reaction consisted of 10 mL of cDNA, a forward and
reverse primer pair for one of the segments at 1 uM each, 16PCR
Buffer II, 1.25 mM MgCl2, (Applied Biosystems) 2.5 U FastStart
Taq (Roche), with a total reaction volume of 50 mL. Samples were
amplified on a GeneAmp 9700 thermocycler (Applied Biosystems)
under the following conditions: 5 min at 95uC, six 3-step cycles at
95uC for 45 sec, 68uC (with a decrease of 2uC/cycle) for 5 min,
and 72uC for 1 min, then five 3-step cycles of 95uC for 45 sec,
54uC for 2 min, and 72uC for 1 min, then 32 3-step cycles at 95uC
for 45 sec, 52uC for 2 min, and 72uC for 1 min, and ended with a
10 min incubation at 72uC.
Sequencing
The concentration of amplicon was determined using a DNA
7500 kit and DNA microfluidics chip as per the manufacturer’s
protocol on a 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA). The amplicon was then purified using the QIAquick
PCR purification kit (Qiagen) following the manufacturer’s
protocol for a 50 mL sample.
Segments shown to contain multiple bands via the 2100
Bioanalyzer, were prone to sequence data with persistent high
background. To rectify this issue, these samples underwent a gel
purification step using a 1% agarose gel run with 16TAE Buffer.
The band of the appropriate size was excised and purified using
Qiagen’s QIAquick Gel Purification Kit following the manufac-
turer’s protocol for PCR purification with spin columns.
Sample purity and concentration was confirmed using the 2100
Bioanalyzer.
Purified amplicon was diluted based on the 2100 Bioanalyzer
results to a final concentration of ,10 ng/rxn. Using a 384-well
plate, 10 mL reactions were set up containing 5 mL of the diluted
amplicon, a sequencing primer at 0.3 mM, 16Big Dye buffer
(Applied Biosystems), 0.225 mL of Big Dye Ready Reaction Mix v
3.1 (Applied Biosystems), and DEPC Water. When running all
12–13 segments for a complete RSV genome, 87–96 different
primers were used (Table S1), allowing for the sequencing of 4
complete genomes for a given 384-well plate. The 384-well plate
was sealed using a well-covering layer of Microseal ‘A’ Film (Bio-
Rad, Hercules, CA) and an outer layer of Adhesive foil for
Microplates (VWR, Radnor, PA). The sealed plate was pulse
centrifuged and PCR was performed in a DNA Engine
thermocycler (Bio-Rad) using the following protocol: 96uCf o r
5 sec then 40 3-step cycles at 96uC for 10 sec, 52uC for 5 sec, and
60uC for 4 min. After the sequencing reaction, the plate was
pulse centrifuged and cleaned up on the automated Biomek FX
fluid handler system (Beckman Coulter, Inc., Brea, CA) by first
adding 20 mL of wash buffer (Millipore, Billerica, MA) to the
samples. All plate contents were then moved to a 384-well filter
plate and placed on an active vacuum manifold for 8 min. The
filter plate was removed from the vacuum and 20 mL of injection
solution (Millipore) was added to each well. The contents of the
vacuum plate were transferred to a new 384-well plate and were
pulse centrifuged. The sequencing reaction was read using a 3730
DNA Analyzer (Applied Biosystems). The sequencing was
sometimes repeated with additional primers to close gaps
remaining in the genomes.
Sequence Data Analysis
Sequence assembly and consensus calling was performed using
SeqMan Pro of the Lasergene 8 program suite (DNASTAR,
Madison, WI). Reference sequences used for assembly were
dependant on the subtype of RSV being analyzed. RSV A and B
genomes were assembled using GenBank sequences U39662 and
AY353550, respectively. Consensus sequences were exported for
use in subsequent phylogenetic analyses.
Phylogenetic Analysis
For each RSV subtype alignments for the whole genome and
the coding sequence (CDS) of each protein (NS1, NS2, N, M, P,
G, F, SH, M2-1, M2-2, and L) were made with additional
published sequences available in GenBank using the multiple
sequence alignment program MAFFT [22]. An additional
alignment was made using the C-terminal region of the G protein
coding sequences that has been described previously [7,9,16,17].
Editing and reformatting of the alignments were made using CLC
Sequence Viewer 6.4 (http://www.clcbio.com) and BioEdit
7.0.5.3 [23]. The best model of evolution for the sequencing data
was determined by employing the GTR+G model of nucleotide
substitution as determined by MODELTEST. This facilitated the
inference of the evolutionary relationship for the complete data set
analyzed in this work for RSV A and RSV B. Trees were made for
each alignment using a Bayesian analysis with the program
MrBayes (version 3.1.2) [24] with at least 1610
6 generations. For
support, trees were also made using the neighbor-joining and
maximum parsimony methods in PAUP* (portable version 4.0b10)
[25]. Tree manipulations were made using the FigTree v1.3.1
program (available at http://tree.bio.ed.ac.uk/software/figtree/).
Synonymous and Non-synonymous Mutations
Mutations in each CDS (CoDing Sequence) were analyzed by
the method of Nei and Gojobori [26]. Codon aligned sequences
for each genome were run through the SNAP program (http://
www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html) [27] to
calculate the variability for each CDS in both RSV A and B.
Alignments included the CDS sequences from the available whole
genomes for RSV A (AY911262, FJ614813, M74568, and
U39662) and RSV B (AF013254 and AY353550).
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The intragenotype divergence was measured as the average of
the synonymous versus non-synonymous mutation ratio (dS)/(dN)
for the four RSV A genotypes found in Milwaukee between
1998–2010. The SNAP program [27] was used for these
calculations.
Intergenic Sequence Analysis
As a measurement of the variability of each intergenic (IG)
region we calculated the percent identity of each IG region for
each of the 33 stains compared to the correspondent IG sequences
(IGS) of the prototype strain A2 (M74568) for RSV A and strain
9320/77 (AY353550) for RSV B. After alignment of the IGS of
the prototype strain with the IGS of our strains, we counted the
number of positions in our strains that are identical to the
prototype sequence and divided by the total number of nucleotide
positions in that IGS. This was examined for each one of the eight
IGS connecting the following RSV genes (39-NS1-NS2-N-P-M-
SH-G-F-M2-59). Since the M2 and L genes overlap there is no
IGS between them to analyze.
Gene Start and End Sequences
Using the whole genome alignments the gene start (GS) and
gene end (GE) sequences were identified using previously
identified sequences for the A2 strain for RSV A. Because not
all GE sequences were described for RSV B we used either
previously published sequences for strain 18537 or by comparison
to the locations and sequences in RSV A.
Non-coding Regions Analysis
As a measurement of conservation/variation of the 59 and 39
non-coding regions (NCR) of each RSV gene we calculated the
percent of conserved nucleotides in each NCR for each of the 25
RSV A stains compared to the correspondent NCRs of the
prototype strain A2 (M74568) for RSV A. After alignment of the
NCRs of the prototype strain with the NCRs of our strains, we
counted the number of positions in our strains that are identical to
the prototype sequence divided by the total number of nucleotide
positions in that NCR. The same conservation/variation of the
59NCRs and 39NCRs in the nine RSV B strains from Milwaukee
was calculated but the strains were compared with each other
instead of comparing with the RSV B prototype strain. This was
examined for all eleven RSV genes excluding the GS, GE, start
codon, and stop codon sequences.
Entropy Plot and Graphical Representation of Variation
and Conservation
Using BioEdit 7.0.5.3 [23] an entropy plot was calculated with
the RSV A and B genome alignments to determine which
positions had variation. The positional information was imported
into Microsoft Excel. Corrected values were calculated for all
positions that were missing information in any of the sequences.
The corrected values, positions of coding regions, and positions of
non-coding regions were plotted in a bar graph format.
Sequences obtained in the course of this study have been
submitted to GenBank and assigned accession numbers:
JF920046, JF920047, JF920048, JF920049, JF920050, JF920051,
JF920052, JF920053, JF920054, JF920055, JF20056, JF920057,
JF920058, JF920059, JF920060, JF920061, JF920062, JF920063,
JF920064, JF920065, JF920066, JF920067, JF920068, JF920069,
JF920070, JN032115, JN032116 JN032117 JN032118 JN032119,
JN032120, JN032121, JN032122, JN032123.
Results
Phylogenetic Analysis
In this work a total of 25 RSV A and 9 RSV B strains were
sequenced and analyzed. We were able to assemble a single contig
covering the complete coding sequence for 13 of the 25 RSV A
and for 4 of the 9 RSV B strains sequenced. The remaining 12
RSV A and 5 RSV B sequences cover the majority of the genome
but have small gaps throughout the genome (Table 1).
RSV A and RSV B sequences were analyzed by neighbor-
joining, maximum parsimony and Bayesian phylogeny methods.
The topography of the trees for the individual CDSs generally
agreed with the trees of the whole genomes for RSV A and RSV B
(Figures 1 and 2). All three methods produced the same
phylogenies showing well supported tree topologies. Likewise,
the phylogenetic trees for the G protein CDS and its highly
variable C-terminal domain had very similar topology for RSV A
(Figure 3) and RSV B (Figure 4).
All RSV A sequences grouped with previously assigned
genotypes, GA1, GA2, GA5 and GA7 (Figures 1 and 3). This
shows a high diversity in the Milwaukee area where these
genotypes co-circulated during the 1997–1998 and 2006–2007
seasons, and genotype GA2 persisting during the last 13 years
(from 1998–2010) and genotype GA5 persisting at least for 11
years (during 1996–2007). Previous studies reported the same
stability of the genotype GA2 for more than 20 years in Sweden
during 1976–2004 [28], and 7 years in Argentina during 1997–
2004 [29]. Genotype GA1 was considerably divergent from the
other genotypes as shown by other authors before [7]. Interest-
ingly, two strains (A/WI/629-3/06-07 and A/WI/629-9/06-07)
isolated in Milwaukee grouped together in GA1 with the prototype
strain A2 isolated in 1961. Temporal and geographical clustering
have been previously described for RSV worldwide [7,8,29–33].
Most notably, GA2 shows sub-clades corresponding with the year
of collection suggesting a temporal relationship rather than
geographical (Figures 1 and 3). Genotype GA2 is the most
geographically diverse containing sequences from USA, China,
Japan, Brazil, Uruguay, Argentina, Ireland, Germany, Istanbul,
and South Africa (Figure 3).
For RSV B the neighbor-joining and maximum parsimony trees
generally supported the topology of the Bayesian trees with slight
variations primarily in the shorter CDSs (SH and M2-2) which did
not have enough variation to achieve adequate resolution (data not
shown). The phylogenetic tree for the RSV B genomes show that
all of the sequences from our local strains have little variation and
appear to all be from a single clade. This is supported by the trees
for the G protein CDS and C-terminal domain in which the
Milwaukee sequences cluster separately from the majority of the
published sequences for this CDS. Most of the individual CDS
trees had lower resolution due to the low amount of overall
variation in RSV B (not shown). All of our RSV B genome
sequences had significantly less variation between each other than
they did with the two published genomes. A tree of the G gene
revealed that all of RSV B sequences from this study were in a
separate clade from all of the published sequences except for one
strain named BA/100/04 (DQ227395) which was collected in
Argentina in 2004 (Figure 4). This strain was sequenced as part of
a study of 38 BA genotype RSV B strains in which the entire G
protein CDS had been sequenced, 35 of which are present in our
tree (Figure 4) [10]. In that study BA/100/04 was classified as
belonging to the BA-IV subgroup. Not surprisingly, there was also
clear separation between the BA and non-BA genotypes in both
trees.
Evolution of Respiratory Syncytial Virus A and B
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The data from SNAP shows that for all CDSs there was more
variation in RSV A than RSV B sequences (Table 2). However,
the number of non-synonymous mutations was slightly higher in
some of the RSV B CDSs (NS1, NS2, M, and M2-1). The CDSs
with the highest dN/dS values were those for the G, M2-2, and
SH CDSs. Interestingly, the fact that the SH, G, and M2-2 CDSs
have the highest ratios of non-synonymous mutations within each
subgroup correlates with the fact that these three proteins also
have the lowest amino acid identity between RSV A and B [34]. In
RSV B 59% of the variable sites are accounted for by differences
between the published sequences from strains that date back more
than 26 years and our sequences (2006–2010). The RSV A
genome analysis demonstrated that only 10% of the observed
variation comes from the difference between our isolates and
previously published sequences.
Genotype divergence
The dS/dN rate has been used as an indicator of selective
pressure with dS/dN=1 meaning neutral mutation, dS/dN.1
Figure 1. Phylogenetic tree of the RSV group A whole genome from Milwaukee and published strains. Branches are colored coded
according to the four different genotypes: GA1 (red), GA2 (blue), GA7 (orange), GA5 (green). The GA2 sub-clades corresponding to the year of
collection are highlighted (in the orange box are the strains collected in 1998, in the yellow box are the strains collected in 2010, and in the blue box
are the strains collected between 2007–2009). The tree was calculated using 1610
6 generations and a burn in of 12 in MrBayes. Node values
correspond to posterior probabilities.
doi:10.1371/journal.pone.0025468.g001
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meaning positive selection [35]. GA2 has an average dS/dN of
1.025 which indicates the most neutral selection while the other
genotypes GA1 (1.23), GA7 (1.28) and GA5 (2.31) showed signs of
purifying selection.
Intergenic Sequence Analysis
The intergenic sequences (IGS) vary in length (1–52 nt) in RSV
A, and (3–55 nt) in RSV B. Comparing each of the IGS of the
strains to the correspondent IGS of the prototype A2 strain found
that two strains (A/WI/629-3/06-07 and A/WI/629-9/06-07)
have identical sequences for all eight IGS analyzed. The average
identity to A2 calculated for all IGS ranged from 33% for P/M (due
to a five nt deletion) to 89% for NS1/NS2 and F/M2 (Table 3).
In general, the Milwaukeestrains belongingto the samegenotype
had intergenic regions that were more similar to each other than to
another genotype or to A2 as described previously [36].
Additionally, the M/SH, G/F, and F/M2 sequences presented a
conserved pattern characteristic of each of the four genotypes
described for the Milwaukee strains (Table 4). The two strains with
identical IGS to A2 described above belong to the same genotype
GA1 and we observed that the IGS of GA1.GA7.GA5.GA2
exhibit the highest to the lowest identity to A2. RSV B strains
showed IGS identity to the prototype strain 9320/77 between 86–
91% which were comparable to the IGS for RSV A.
Gene start and end sequences
All Paramyxoviruses have been shown to contain conserved gene
start(GS)andgeneend(GE)sequences[6].ForRSVA alloftheGS
and GE sequences have been described and analyses have been
performed to identify the functional importance of differences
within and around these sequences [36–40]. To our knowledge the
GS and GE sequences have only been described for 7 of the genes
(NS1, NS2, N, M, G, F, and M2) in RSV B despite the existence of
two complete wild-type genomes for this subgroup [41] and no
functional studies have beenperformed. The remaining GS and GE
sequences for RSV B were identified based on their positional and
sequence similarity to their respective sequences in RSV A. In both
RSV A and B the GS consensus sequence is 39-CCCCGUUUA-59
with the only exception being the L gene in both RSV A and B (39-
CCCUGUUUU-59) and the SH gene in RSV B (39-
CCCCAUUUA-59) (Table 5). The GS sequences were 100%
conserved in all of the strains we sequenced for both RSV A and B.
In RSV A the GE consensus has been described as (39 -
UCAAUN1–4U4–7 - 59) and it has been suggested that it should
include an ‘‘A’’ at the 39 end which is conserved in 8 of the 10 GE
sequences in RSV A [6] and 9 of the 10 GE sequences in RSV B
(Table 5). Most variation has been found in the central
unconserved region and in the length of the U tract while the
UCAAU region is largely conserved, however, there are some
notable exceptions. The most common variation of this region is
UCAUU and has been identified in the NS2 GE in both RSV A
and B, the N GE of RSV A and the P GE of RSV B. Another,
variation (UCAGU) has been shown to be present in the G GE for
all RSV A strains that don’t belong to the GA1 genotype [36].
This includes 23 of the strains sequenced in our study. For the M
GE in RSV B all strains have UCCAU for this region. All other
GE sequences observed for RSV A and B matched the consensus
Figure 2. Phylogenetic tree of the RSV B whole genomes from Milwaukee and the two published genome sequences. The tree was
calculated using 5610
6 generations in MrBayes and a burn in of 15. Node values are posterior probabilities. (In parenthesis are the published strain
names).
doi:10.1371/journal.pone.0025468.g002
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sequences in this study the only GE sequence that is completely
conserved in all sequences for RSV A is that of the M2 gene [36].
For RSV B the GE sequences for the NS1, N, P, M, and F genes
were conserved in both the sequences published in this study and
the two published whole genomes. Between RSV A and B only 3
genes (NS1, M2, and L) had a GE variant that was shared between
both groups. For all other genes there were one or two differences
between GE sequences.
Non-coding Regions Analysis
The analysis of the 59NCRs and 39NCRs for each RSV gene
(Table 3) shows that the 59NCRs are generally shorter than the
39NCRs for each gene and the short ones (4–8 bp) are 100%
conserved in RSV group A and B. In general, the 39NCRs
presented more variation than the 59NCRs for each gene and the
most variable ones are present in: the G gene for RSV A, the M
gene for RSV B, and in the SH gene for RSV A and B (Table 3),
(Figure 5). The 39NCRs in RSV A were 4–22% more variable
than the 39NCRs in RSV B, with the highest variation observed in
the G gene. 59NCRs and 39NCRs were 100% conserved for
sequences belonging to GA1 and the most variable 39NCRs were
found in sequences of the G gene belonging to GA2 and GA7
(data not shown). Genotype-specific patterns were observed for
most of the NCR in RSV A especially for NS1, NS2, P and the
39NCR of the L gene. Patterns were not observed in short NCRs.
For RSV B we could not find any pattern characteristic of
genotype due to the lack of genetic variation in this subtype.
Glycoprotein Gene Insertions and Deletions
For the glycoprotein (G) gene we identified three RSV strains
that had mutations which should cause pre-mature stop codons.
RSV A strain 629–4285 has a 2 bp mutation that changed codon
212 from AAA to TGA and is predicted to cause the G protein to
be truncated to 211 amino acids. Two RSV B strains (629-12 and
629-DC10) were identified to contain a single nucleotide deletion
within the glycoprotein CDS. In 629-12 this deletion occurred at
position 582 of the CDS and caused a pre-mature stop codon at
amino acid position 198 of the G protein which would otherwise
be 310 amino acids long. For 629-DC10 the deletion occurred at
nucleotide position 690 which would cause a stop codon at amino
acid 233. Analysis of the chromatograms for this region suggest
that in this sample there is actually a mixed population of RSV in
which some virus particles contain this deletion and some do not.
While not necessarily related, we did attempt to isolate 629–4285
and 629-DC10 in tissue culture, but were unsuccessful. Since we
were not able to isolate these strains and did not have enough
material to do more testing we could not verify their viability. It
has previously been shown in vitro that RSV mutants lacking the G
gene are still able to form infectious particles and replicate
although less efficiently [42], it is possible to generate RSV strains
with truncated G proteins in vitro using sub-neutralizing levels
antibody [43], and RSV with a truncated G protein has even been
isolated from an immunocompromised patient [44]. Therefore, it
is certainly possible that an individual could develop a respiratory-
tract infection with a strain of RSV containing a truncated version
of the G protein.
Also, all of the Milwaukee RSV B sequences contained the
60 bp insertion (positions 5465–5525 in Figure 5) characteristic of
the BA genotype and a 6 bp deletion between positions 470–480
relative to the reference sequences. The exact 6 bp deleted cannot
be determined due to repetition in this region. This same deletion
was present in three other published sequences (DQ227395,
DQ270232, and DQ270233). Interestingly DQ270232 and
DQ270233 do not belong to the BA genotype and this deletion
was not present in the majority of published BA genotype
sequences which suggests that this deletion has occurred on at least
two separate occasions [45].
Discussion
We report the successful development of a rapid strategy for
whole genome sequencing for RSV and the results of applying it to
34 RSV positive clinical samples collected over a 13 year time
period. In addition we have reported the analysis of this genomic
data and comparison to all relevant RSV genomic data available
in GenBank.
Significant diversity among RSV A Milwaukee strains was
observed and can be explained by the co-circulation of multiple
genotypes within and across seasons. GA2 and GA5 co-circulated
in two different seasons (1998 and 2006) after which apparently
only GA2 persisted, still infecting people in the Milwaukee area in
2010. These results are consistent with other published studies for
RSV A [29,46] where they also had shown that several genotypes
are present now, were present in 1996, and were even present
much earlier as can be seen by the fact that published sequences
from as far back as 1956 fall into these same genotypes (Figure 3).
These genotypes appear to have much more distant origins and
continue to co-circulate with each genotype steadily accumulating
unique mutations. So the significant amount of variation in RSV A
is primarily due to the presence of co-circulating genotypes rather
than the rapid accumulation of mutations over a short period of
time.
A similar situation can be described in our community with the
strains A/WI/629-3/06-07 and A/WI/629-9/06-07 isolated
during the 2006/2007 season and which belong to the same
lineage (GA1) as the prototype strain A2 isolated almost 50 years
ago (Figures 1 and 3). These two strains show surprising similarity
to the published A2 sequence (M74568) with only 15 and 19
mutations respectively, but they are actually more similar to
mutant strains of the virus (U50362, U50363, and U63644). We
do have the A2 ATCC strain (VR-1540) in our lab so there is some
possibility of contamination with this strain in these samples even
though the ATCC strain was not used in this study or in use when
sequencing these strains. Since A/WI/629-9/06-07 was se-
quenced directly from a clinical sample and has the most
mutations compared to the published A2 sequence contamination
with the ATCC strain or A/WI/629-3/06-07 seems unlikely.
Another possibility is that the A2 strain may have been
accidentally re-introduced into the population through exposure
of laboratory workers, which could also explain the relatively few
mutations. Furthermore, although GA1 has not been observed in
the last 15 years in European countries, South America or North
America, it has been detected again in the last 4 years not only in
Milwaukee but also in South Asia as reported recently (GenBank:
Figure 3. Phylogenetic tree of the highly variable C-terminal domain of the G protein CDS of RSV A. Strains worldwide already
published are identified with the GenBank identification number and in parenthesis are the correspondent published strain names with the last two
numbers of the year of collection and where NA denotes that the collection date was not available. The 25 sequences from the Milwaukee strains are
highlighted. The tree was calculated using 1610
6 generations and a burn in of 50 in MrBayes. Node values correspond to posterior probabilities.
doi:10.1371/journal.pone.0025468.g003
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this genotype may have been re-introduced into North America or
continued circulating at least until 2007 in Milwaukee. Unfortu-
nately, the lack of molecular epidemiological studies in the USA
for the last 12 years makes it difficult to determine whether this
lineage has reemerged or has been continuously circulating during
this time.
Other authors demonstrated that the continuous circulation of
strains belonging to the genotype GA2 worldwide, and for which
more amino acid changes were observed, compared with strains
belonging to other genotypes, is due to positive selection pressure
[47–49]. Although the limited number of samples sequenced in
this study per year precludes definitive conclusions about the
periods of circulation of different genotypes in Milwaukee, the
more amino acid changes observed in GA2 compared with other
genotypes correlate with the continuous and potentially longer
circulation of GA2 relative to other genotypes noted in our
community. A more accurate picture of the persistence and co-
circulation of other genotypes could have been determined with
the inclusion of more strains.
The C-terminal region of the G-protein has beendescribed as the
most variable one between and within RSV group A and B and has
been designated as the most reliable to describe the evolutionary
changes of RSV [7,50]. Since Peret et al. reported in 1998 for the
firsttimetheexistenceofdifferentgenotypesbasedontheanalysisof
this short C-terminal part of the G gene, the majority of the
evolutionary and molecular studies carried out on RSV A and B
havebeen focused on this region[7].To date, our knowledgeon the
molecular evolution of RSV is mainly based on studies done using
theC-terminalregion,whichjustaccountsfor2%ofthewholeRSV
genome. In this report we were able to independently confirm this
hypothesis using the entire RSV genome and demonstrate that the
same evolutionary pattern and clades were seen with the whole
genome as with the G protein CDS and its C-terminal.
Interestingly, we also observed genotype-specific patterns through-
out other parts of the RSV A genome namely the IG sequences and
the NCRs revealing that the nucleotide phylogeny of RSV A is
consistent across its whole genome. This particular characteristic
suggests that not only the commonly used C-terminal of the G gene
allows for genotyping but also that other parts of the genome are
important to describe evolution in RSV A as well. Since the C-
terminus of the G protein CDS is still the most variable allowing for
the best discrimination between strains and has been used by the
majority of the evolutionary studies it is recommended to continue
to use this regionforgenotyping when largerportionsofthegenome
are incapable of being sequenced so as to maintain comparability
between studies.
The situation was quite different for RSV B. Previous studies
identified a new genotype of RSV B which contained a 60 nt
duplication in the C-terminus of the glycoprotein gene. This
genotype was first identified in samples collected in Buenos Aires
during the 1999 RSV season and given the designation BA [11].
Later studies identified this genotype in samples collected in Spain
and Belgium also during 1999 and in one sample collected in
December of 1998 [12,51]. Since the BA genotype was already
present in both South America and Europe in 1999 and there was
little variation between the sections of the G gene sequenced in
these studies, it is believed that the 60 bp insertion event must have
occurred no more than one or two years earlier. However, since
no studies have yet identified BA strains in earlier seasons, it is
possible that the first occurrence was in Europe during the 1998/
1999 season. Multiple studies have demonstrated that since this
insertion first occurred the BA genotype has spread worldwide and
become the dominant RSV B genotype [10,12,51,52]. Therefore,
it is not surprising that all of the RSV B strains identified in our
study (2006–2010) belong to the BA genotype. Since all of the
RSV B sequences in our study are from this relatively recent
genotype it is also not surprising that we saw a small amount of
variation between sequences with most of the total variation
observed coming from differences between our sequences and the
Figure 4. Phylogenetic tree of the whole G protein CDS of RSV B. The sequences from Milwaukee are colored and highlighted in red and the
sequences from non-BA genotypes are colored in blue. Node values correspond to posterior probabilities. The tree was calculated using 3610
6
generations and a burn in of 170 in MrBayes. (In parenthesis are the published strain names). Strains worldwide already published are identified with
the GenBank identification number and in parenthesis are the correspondent published strain names with the last two numbers of the year of
collection and where NA denotes that the collection date was not available.
doi:10.1371/journal.pone.0025468.g004
Table 2. Variation of each coding sequence in RSV A and B.
Gene RSV A RSVB
Average dS Average dN dN/dS
Total
Sites
Variable
Sites Average dS Average dN dN/dS
Total
Sites Variable Sites
NS1 0.1285 0.0022 0.017 420 42 0.0478 0.0044 0.092 420 20
NS2 0.1224 0.0037 0.030 375 37 0.0710 0.0037 0.052 375 25
N 0.1229 0.0018 0.015 1176 117 0.0389 0.0008 0.019 1176 42
P 0.0876 0.0034 0.039 726 57 0.0710 0.0028 0.040 726 45
M 0.1008 0.0008 0.008 771 59 0.0432 0.0013 0.031 771 34
SH 0.1123 0.0052 0.046 195 19 0.0258 0.0045 0.173 198 7
G 0.1041 0.0478 0.460 897 202 0.0520 0.0195 0.376 939 111
F 0.1196 0.0058 0.049 1725 190 0.0598 0.0024 0.040 1725 88
M2-1 0.1021 0.0056 0.054 585 55 0.0745 0.0064 0.086 588 38
M2-2 0.0585 0.0286 0.488 267 33 0.0517 0.0080 0.155 273 16
L 0.1042 0.0044 0.042 6498 593 0.0494 0.0021 0.042 6501 287
doi:10.1371/journal.pone.0025468.t002
Evolution of Respiratory Syncytial Virus A and B
PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e25468previously published RSV B genome sequences. While the data
from our study for the CDS regions, GS and GE sequences, 59 and
39NCRs, and IGS all suggest that there is less variation in RSV B
than RSV A, a previous study looking at a 724 bp region of the G
gene for 196 RSV B strains from 22 seasons (1982–2004) found
that the evolutionary rates for this gene were very similar to that
observed in RSV A [12]. This discrepancy is most likely due to our
limited data set and it would therefore be important to do a larger
study for RSV B incorporating strains from other genotypes that
occurred in previous seasons.
When comparing all eight IGS of the Milwaukee strains with
the prototype strains for RSV A and RSV B (GenBank: M74568
and AY353550), very low variability over the last 50 and 34 years
respectively was observed. The degree of variation in the
intergenic sequences seen for the RSV Milwaukee strains group
A and group B agreed with previous studies on RSV A clinical
isolates from the USA and UK [36]. Unlike some Paramyxoviruses
that present conserved or semi-conserved di- or trinucleotide IGS
patterns [34,53–55] RSV shows longer and more variable IGS
regions.
In RSV, transcription starts at a single promoter located at the
39 end of the genome. After binding to that promoter the
polymerase scans towards the 59 end of the genome until it reaches
a specific GS sequence which initiates transcription of the mRNA
for each gene. The polymerase continues to produce the mRNA
until it reaches a GE sequence. Depending on the sequence of the
GE it will either stop producing mRNA (terminate) or continue
through the next gene until it reaches another GE sequence
Table 4. Intergenic region sequences for RSV A strains from Milwaukee and genotype patterns.
Intergenic regions Sequence 39R59
a Genotype
SH-G (44) UAGUCAUAACAAUGAACUAGGAUAUCAAGACUAACAAUAACAUU GA1
.........................U.....C..A..C..UGC. GA2 (2010)
................U........U.....C..A..C...G.. GA2 (2007–2009)
...................A.....U.....C.....C...G.. GA2 (1998)
...................A.....U...........C...G.. GA5
...................AA....U...............G.. GA7
G-F (52) CAUAUUAUCACAAAAAGCCAUGACCAACUUAAACAGAAUCAAAAUAAACUCU GA1
.G....G.UG.................A.C.....U.........C...... GA2
.G......UG......A..........A...................G.... GA5
.G......UG.................A.C...............C...... GA7
F-M2 (48) CACAAUUGAAUGCCAGAUUAACUUACCAUCUGUAAAAAUGAAAACUG GA1
-..........A...A..........U..U...........G..... GA2
-..........A..............U..U...........G..... GA5
-..........A..............U..U................. GA7
aAfter alignment of the IGS of the prototype strain A2 with the IGS of the Milwaukee strains, a comparison was made to find out the identical/variable nucleotides.
Identical nucleotides are represented by a ‘‘.’’ while variable nucleotides are represented by their nucleotide difference when compared to the prototype strain. These
differences are what make up the genotype-specific patterns.
doi:10.1371/journal.pone.0025468.t004
Table 3. Lengths and conservation of the NCR and IGS regions in RSV A and B.
Gene RSV A RSV B
59NCR
Length
a
Conser-
vation (%)
39NCR
Length
Conser-
vation (%)
Intergenic
Length
Conser-
vation (%)
59NCR
Length
a
Conser-
vation (%)
39NCR
Length
Conser-
vation (%)
Intergenic
Length
Conser-
vation (%)
NS1 45 95.56 45 95.56 19 89.47 45 95.56 45 95.56 17 100
NS2 23 91.3 73 89.04 26 84.62 23 86.96 85 92.94 26 (29) 88.46
N 6 83.33 0 - 1 (2)
b 100 6 100 0 - 3 100
P 8 100 156 (155) 84.62 9 (4,5) 33 8 100 158 94.94 9 100
M 0 - 165 83.03 9 (8) 77.78 0 - 162 89.51 9 88.89
SH 75 78.67 121 76.86 44 86.36 76 90.79 117 87.18 44 86.36
G 6 100 61 73.77 52 88.46 6 100 19 94.74 52 98.08
F 4 100 65 87.69 46 89.13 4 100 150 (151) 93.33 55 94.55
M2 0 --- --0 - - ---
L - - 60 (54,61) 90 - - - - 58 98.28 - -
aLengths do not include GS, GE, start codon, or stop codon sequences.
Values in parentheses indicate alternate lengths observed, excluding those limited to previously published sequences since they cannot be verified.
doi:10.1371/journal.pone.0025468.t003
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always initiated at the 39 end of the genome and some percentage
of the polymerase falls off at each GE sequence the number of
mRNAs transcribed for each gene decreases proportionately from
the 39 end to the 59 end of the genome.[36]. This in turn leads to
decreased protein produced for genes at the 59 end of the genome
[36,56]. It is in this manner that the termination efficiency of the
GE seems to be used by RSV to regulate the production of its
proteins. Multiple studies have shown that the transcription
termination efficiency is principally regulated by the specific GE
sequence with a little influence from individual bases of the
39NCR and IGS of a gene [36–38,40,56]. The GE of the RSV A
SH gene has been described as the ideal termination sequence and
its high termination efficiency is evidenced by the lack of
detectable SH-G dicistronic mRNA in cell culture. Additional
studies have directly measured its termination efficiency [6,40].
Detailed mutational studies have been performed with GE
sequences from RSV A identifying that different mutations in
various individual positions or combinations of positions can have
a significant impact on termination efficiency [36,38,39]. Muta-
tions in the UCAAU region in particular caused a significant
decrease in termination efficiency. Since the GE sequences
between RSV A and B are similar it is likely variations in RSV
B GE sequences would have a similar impact on termination
efficiencies. For example, since the matrix gene GE in all RSV B
sequences contained an A-.C mutation in the UCAAU region it
is possible that termination efficiency is reduced at this location
which could result in a decrease in the production of the SH
protein during RSV B infection compared to that of RSV A. The
additional variations that we identified for RSV A further
highlight just how variable these GE sequences are. The most
common variation that we saw was a change in the length of the
U-tract. It has previously been shown that longer U-tracts have
increased termination efficiency and are less sensitive to mutations
Table 5. The gene end sequences of RSV A and B.
Gene RSV A RSV B
Gene End Sequences 39R59
a
Number of
Strains
b Gene End Sequences 39R59 Number of Strains
NS1 UCAAUUAUAUUUU (A2) 24 UCAAUUAUAUUUUU (9320) 0
UCAAUUAUAUUUU 9
NS2 UCAUU-AAAUUUU (A2) 13 UCAUU–AAUUUUU (9320) 9
UCAAU-AAAUUUU 12
N UCAAUU–AUUUUUU (A2) 17 UCAAUU–GUUUUUU (9320) 9
UCAAUU–AUUUUUUU (19) 4
UCAAUU–AUUUUUUUU (S2) 0
UCAUU–AUUUUUU 1
P UCAAU–GUUUUUUU (A2) 23 UCAUU–GUUUUUUU (9320) 9
UCAAU–GUUUUUU 1
UCAAU–GAUUUUUU 1
M UCAAUU–AUUUUUU
c (A2) 12 UCCAUU-UAUUUU (9320) 9
UCAAUU–AUUUUU (Long,S2) 13
UCAAUU–AUUUUUUU
c 1
UCAAUU-ACUUUUU 1
SH UCAAUU-AAUUUUU (A2) 17 UCAAU-AAAUUUU (9320) 7
UCAAUU-AAUUUUUU 7 UCAAU-AAAUUUUU 2
UCAAUU-AAUUUUUUU 1
G UCAAU-GAAUUUUU (A2) 2 UCAAU-AAGUUUUU (9320) 0
UCAAU–AAUUUUUU (Long,19) 0 UCAAU-AAAUUUUU 7
UCAGU–AAUUUUU (S2) 23
F UCAAU-AUAUUUU (A2) 20 UCAAU-GUAUUUU (9320) 8
UCAAU-AUAUUUUU 4
M2 UCAAU-AAAUUUU (A2) 23 UCAAU-AGAUUUU (9320) 7
UCAAU-AAAUUUU (B1) 0
L UCAAU–AAUUUUU (A2) 2 UCAAU–AAUUUUU (9320) 8
UCAAU–AAUUUUUU (Long,19) 0 UCAAU–AAUUUU 1
UCAAU-AAAUUUU 23
aBold sequences have not been previously identified by Moudy 2003 or in published genomes. Dash characters have been added to the central domain so that the U-
tracts line up. Sequences that are found in the published genomes are marked with that strain in parentheses. Genomes other than A2 for RSV A and 9320 for RSV B are
only listed if they have a different GE sequence.
bThese numbers only include strains sequenced in this study.
c629-Q0198 is a mix of 6 and 7 U’s but was only added to the GE with 6 U’s.
doi:10.1371/journal.pone.0025468.t005
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B we saw less variation within GE sequences for each individual
gene with half of them showing no variations and the remaining
genes only having two variants each. It is possible that RSV B is
more sensitive to changes in termination efficiency so that there is
more selective pressure preventing changes in the GE sequences.
However, the lack of variation could also just be an artifact of
small sample size primarily from a single genotype that is relatively
young. More sequences from older RSV B non-BA genotypes
would provide a more accurate picture of the true RSV B GE
diversity.
RSV is a health concern worldwide causing significant
morbidity, mortality and cost to our society [57]. The sequencing
method presented in this work allows four RSV genomes to be
sequenced simultaneously in as little as two working days. The low
cost and ability to perform this assay on clinical specimens could
increase its use as a routine clinical assay. Our study significantly
increased the amount of genomic data available for this important
respiratory pathogen. With this additional genomic data we
identified variable regions throughout the genome that may be
beneficial for evolutionary studies and conserved regions that will
be beneficial for the development of improved diagnostics. While
our study is limited to strains from Milwaukee collected during the
last 14 years, the data from this study will be beneficial to
comprehensive studies of RSV worldwide. These whole genome
sequences will benefit other communities by eliminating the
dependence on the limited information contained in the tiny
fractions of the RSV genome previously published. Our data
contributes to a better knowledge of the basic molecular structure
of RSV, which will help drive the development of new vaccine
approaches and allow for control and reduction of the disease
burden caused by RSV.
Supporting Information
Figure S1 RNA negative-sense genome and amplifica-
tion strategy of the whole genome of RSV. At the top the
kilobase scale is aligned relative to the RSV genome (approx-
imately to scale). Genes are represented as green rectangles named
according to the encoded protein. At the bottom the 12 PCR
products resulted from the cDNA amplification with 12 overlap-
ping primer sets spanning the entire RSV genome.
(TIF)
Table S1 Primers used for amplification and sequencing.
(DOC)
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